(Q77893184)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10372564%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

title

Cognitive abilities and adjustment with gabapentin: results of a multisite study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10372564%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

author name string

C B Dodrill

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10372564%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

J L Arnett

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10372564%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

A G Hayes

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10372564%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

E A Garofalo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10372564%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

C A Greeley

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10372564%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

M J Greiner

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10372564%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

M W Pierce

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10372564%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

publication date

1 June 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10372564%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10372564%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10372564%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10372564%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

109-121

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10372564%20AND%20SRC:MED&resulttype=core&format=json

Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study. The International Gabapentin Study Group

9 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2899%2900006-6

7 January 2021

Gabapentin add-on therapy with adaptable dosages in 610 patients with partial epilepsy: an open, observational study. The French Gabapentin Collaborative Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2899%2900006-6

7 January 2021

Gabapentin monotherapy: II. A 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 82/83

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2899%2900006-6

7 January 2021

Conversion to high dose gabapentin monotherapy in patients with medically refractory partial epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2899%2900006-6

7 January 2021

A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2899%2900006-6

7 January 2021

Effect of gabapentin (Neurontin) [corrected] on mood and well-being in patients with epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2899%2900006-6

7 January 2021

A neuropsychological battery for epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2899%2900006-6

7 January 2021

An objective method for the assessment of psychological and social problems among epileptics.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2899%2900006-6

7 January 2021

Evaluation of the effects of vigabatrin on cognitive abilities and quality of life in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2899%2900006-6

7 January 2021

Effects of differing dosages of vigabatrin (Sabril) on cognitive abilities and quality of life in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2899%2900006-6

7 January 2021

Effects of tiagabine monotherapy on abilities, adjustment, and mood.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2899%2900006-6

7 January 2021

Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study. The US Gabapentin Study Group No. 5

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2899%2900006-6

7 January 2021

Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2899%2900006-6

7 January 2021

Gabapentin toxicity in children manifesting as behavioral changes.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2899%2900006-6

7 January 2021

An economical method for the evaluation of general intelligence in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2899%2900006-6

7 January 2021